Author: Admin
ZHANGSHU, China, Oct. 23, 2025 /PRNewswire/ — A report from Jiangxi International Communication Center (JXICC): “Without Zhangshu, medicines are incomplete; without Zhangshu, medicines lack efficacy.” On October 16, 2025, Jiangxi’s Zhangshu Qihuang Town was bustling with crowds as the 56th National Medicinal Materials and Pharmaceuticals Trade Fair grandly opened here. Simultaneously, an international youth exploration journey in Jiangxi, themed “From Ancient Wisdom to Modern Wellness,” was launched. This event was jointly organized by the Jiangxi International Communication Center and Jiangxi University of Chinese Medicine, hosted by the Jiangxi Daily Exhibition Business Department, and co-organized by Renhe Group. It invited ten international students from multiple…
NEW YORK — NEW YORK (AP) â Decades into his career and the unthinkable happened. It was 2022, and Jon Bon Jovi began struggling through his songs. He saw a doctor who said one of his vocal cords was atrophying. He needed major surgery. Bon Jovi had the procedure, and in the years since, has undergone extensive rehab, leading to the current moment: Next summer his band, Bon Jovi, will embark on their first tour in four years.The âForever Tourâ kicks off with four nights at New York’s Madison Square Garden before the band heads to Edinburgh, Scotland; Dublin and…
The plot of the new Colleen Hoover adaptation âRegretting Youâ is a little wild. Thereâs romance, an affair, unrequited love, death and even a baby with questionable paternity.Dave Franco, whose character has long pined for Allison Williamsâ character but ends up having a child with her sister who is having an affair with her brother-in-law, said someone recently exclaimed to him, âWhat in the Maury Povich was that?âTabloid talk show fodder though they might be, Hooverâs novels have hit a nerve with audiences and Hollywood. âIt Ends With Usâ made over $350 million worldwide against a $25 million budget and…
STOCKHOLM, Oct. 23, 2025 /PRNewswire/ — Hygiene and health company Essity is today launching measures to create better conditions for profitable growth. Actions include an organizational change that decentralizes decision-making and strengthens end-to-end accountability for each product category, and a cost savings program that is expected to generate annual savings of approximately SEK 1bn with full effect by the end of 2026. “Today, we’re launching measures to create better conditions for Essity to increase its growth rate going forward and to faster achieve our targets,” says Ulrika Kolsrud, President and CEO, Essity. The organizational change will simplify Essity’s structure and create…
SĂO PAULO, Oct. 22, 2025 /PRNewswire/ — MGI Tech Co., Ltd. (“MGI”), a company dedicated to developing essential tools and technologies to drive innovation in the life sciences, has entered into a strategic partnership with Eva Holding Group, a Brazilian group operating in genomics applied to human health, animal health, and agribusiness. The initiative aims to expand Brazilian patients’ access to genomics, including joint efforts in the development of the country’s genetic sector. DNBSEQ-T7 The agreement includes the installation of genetic sequencers that expand public access to cutting-edge genomic technologies and enhance the accuracy…
UConn is ranked No. 4 in the preseason Associated Press Top 25 college basketball poll, but that isn’t impressing Huskies coach Dan Hurley.”There’s nothing more useless than preseason polls and picks,” Hurley said during Big East media day. “Preseason polls are pretty meaningless. I don’t even do mine. I think I told (assistant coach) Luke (Murray) to go do that s—.”It’s a seemingly ironic statement from a coach who just last season said, “We dominate for the national championship, we lose all the players, and then we’re even better. We dominate even more, we lose all the players … I…
KANSAS CITY, Mo., Oct. 22, 2025 /PRNewswire/ — Elevate Holistics, a telehealth leader in medical cannabis recommendation services, today highlights the significant shift in U.S. attitudes and laws toward recreational (adult-use) cannabis, and outlines how the company under CEO Aspen Noonan is positioning itself to responsibly serve patients and consumers in this evolving landscape. Growing Acceptance of Recreational Cannabis canna freedom A number of recent 2025 data points illustrate how adult-use cannabis is increasingly mainstream in the U.S.: As of 2025, adult-use (recreational) cannabis is legal in 24 states plus…
Although LeBron James wasn’t able to play in the Los Angeles Lakers’ season opener, he’s making sure they learn from their loss to Golden State.Coach JJ Redick said James was “really helpful” during a film session Wednesday as the Lakers’ examined their performance in the 119-109 defeat.James won’t be ready to begin his unprecedented 23rd NBA season for at least a few weeks due to sciatica, but he is taking a strong interest in the team’s off-court work in an effort to ensure the Lakers get off to a decent start without him, Redick said.”I told them [that] him asking…
The NCAA approved a rule change on Wednesday that will allow athletes and athletic department staff members to bet on professional sports.Two weeks after the Division I cabinet approved the change, Division II and III management councils signed off on it, allowing the new rule to go into effect Nov. 1.This doesnât change the NCAA rule forbidding athletes from betting on college sports. The NCAA also prohibits sharing information about college competitions with bettors. The institution also doesnât accept advertising or sponsorships of NCAA championships by betting sites.Despite the change, the NCAA emphasized that it doesnât endorse betting on sports,…
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Oct. 22, 2025 /PRNewswire/ — Harbour BioMed (HKEX: 02142), a global biopharmaceutical company focused on the discovery and development of novel antibody therapeutics in immunology and oncology, today announced positive Phase II clinical data for porustobart (HBM4003), a next-generation, fully human heavy-chain-only anti-CTLA-4 antibody, in combination with tislelizumab, in patients with microsatellite stable (MSS) metastatic colorectal cancer (mCRC). The multicenter, open-label Phase II study (NCT05167071) enrolled 24 heavily pretreated patients with non-liver-metastatic (NLM) MSS mCRC. Patients received HBM4003 (0.3 mg/kg) plus tislelizumab (200 mg) every 21 days. The primary efficacy endpoint was objective response rate (ORR)…